BIG PHARMA WATCH: BIG PHARMA ALREADY INCREASING PRICES ON NEW RSV VACCINES TO BOOST PROFITS
Jul 13, 2023
Manufacturers Increasing Prices in Lockstep to Raise Prices Across New Drug… Read More
© 2024 CSRXP- All Rights Reserved
Updates
CSRXP: PROPOSAL TO LOOSEN PATENT RULES WOULD FURTHER EMPOWER BIG PHARMA TO BLOCK COMPETITION
Jun 23, 2023
Lawmakers Should Focus on Bipartisan Solutions to Hold Big Pharma Accountable,… Read More
BIG PHARMA WATCH: BIG PHARMA EXPOSED FOR CONTINUING TO HIKE PRICES FASTER THAN RATE OF INFLATION
Jun 16, 2023
HHS & CMS Announce New Penalties That Help Hold Brand Name Drug Companies… Read More
ICYMI: THE COST OF BIG PHARMA’S EGREGIOUS PATENT ABUSE ON BRAND NAME INHALERS
Jun 2, 2023
Physicians Highlight How Big Pharma Games the System to Boost Profits and… Read More
DOSE OF REALITY: BIG PHARMA’S PATENT ABUSE COSTS AMERICAN PATIENTS OVER $40 BILLION IN JUST ONE YEAR
May 23, 2023
New Analysis Highlights Urgency to Hold Big Pharma Accountable for Egregious… Read More
DOSE OF REALITY: BIG PHARMA TAX AVOIDANCE PRACTICES COME UNDER SCRUTINY IN SENATE FINANCE HEARING
May 12, 2023
Report Finds Big Pharma Games the System to Avoid Paying U.S. Taxes While… Read More
THEY SAID IT! LAWMAKERS SLAM BIG PHARMA CEOS FOR EGREGIOUS PRICING OF BRAND NAME INSULINS
May 12, 2023
Brand Name Drug Giants Refuse to Rule Out Future Insulin Price Hikes On… Read More
CSRXP COMMENDS HELP COMMITTEE FOR ADVANCING BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE
May 11, 2023
Senate Panel Passes Bills to Increase Competition and Increase List Price… Read More
CSRXP: SENATORS HAVE OPPORTUNITY TO PASS BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE
May 11, 2023
U.S. Senate HELP Committee Should Advance Legislation to Boost Competition and… Read More
DOSE OF REALITY: SENATORS MUST HOLD BIG PHARMA ACCOUNTABLE FOR EGREGIOUS INSULIN PRICING PRACTICES
May 9, 2023
Lawmakers Have Opportunity to Grill Big Pharma Executives on Tactics Like… Read More
BIG PHARMA EARNINGS WATCH: PFIZER, MODERNA, ELI LILLY, NOVARTIS, GLAXOSMITHKLINE, ROCHE, AMGEN
May 9, 2023
Brand Name Drug Companies Continue to Hike Prices and Post Record Profits… Read More
CSRXP: MODERNA BRAZENLY IGNORES OUTRAGE BY MOVING AHEAD WITH EGREGIOUS VACCINE PRICE HIKE
May 4, 2023
Nearly 500 Percent Price Increase on Vaccine Developed with Taxpayer… Read More